Showing results (1221-1230 of 1,376) with videos related to

Sort By:
Pageof 138
Brain : a Journal of Neurology|June 4, 1999
Surgical outcome in patients with epilepsy and dual pathologyL M Li, F Cendes, F Andermann, et al.
Journal of the International Neuropsychological Society : JINS|December 2, 2016
Cognitive and Behavioral Functioning in Childhood Acquired Demyelinating SyndromesChristine Till, Austin Noguera, Leonard H Verhey, et al.
Human & Experimental Toxicology|April 19, 2019
Experimental cryptorchidism enhances testicular susceptibility to dibutyl phthalate or acrylamide in Sprague-Dawley ratsN P de Souza, Ap Ferragut Cardoso, Lmm Gomide, et al.
JAMA Neurology|September 24, 2019
Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating SyndromesPatrick Waters, Giulia Fadda, Mark Woodhall, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort studyGiulia Fadda, Robert A Brown, Giulia Longoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 9, 2022
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trialDouglas L Arnold, Daniela Piani-Meier, Amit Bar-Or, et al.
American Journal of Audiology|April 27, 2026
Patient-Centered Hearing Intervention Leads to Positive Outcomes: The Association of Hearing Technology With Daily Hearing Aid Usage and Listening Goals in the Aging and Cognitive Health Evaluation in Elders StudyVictoria A Sanchez, Emmanuel E Garcia Morales, Michelle L Arnold, et al.
BMJ Open|February 25, 2025
Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocolSharika Nuzhat, Md Ridwan Islam, Subhasish Das, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2018
Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II studyJeffrey A Cohen, Giancarlo Comi, Douglas L Arnold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challengeJ I Sin, J J Kim, R L Arnold, et al.
Pageof 138